References
Chomczynski, P.; Sacchi, N. Single step method RNA isolation by acid guanidium thiocyanate phenol-chloroform extraction. Anal. Biochem. 162:156–159; 1987.
Denhardt, D. T.; Guo, X. Osteopontin: a protein with diverse functions. FASEB J. 7:1475–1482; 1993.
Giachelli, C. M.; Bae, N.; Almeida, M., et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92:1686–1696; 1993.
Guo, X.; Zhang, Y. P.; Mitchell, D. A., et al. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol. Cell. Biol. 15:476–487; 1995.
Indolfi, C.; Avvedimento, E. V.; Rapacciuolo, A., et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1:541–544; 1995.
Lovric, J.; Radziwill, G.; Moelling, K. Specific association of Mil/Raf proteins with a 34 kDa phosphoprotein. Oncogene 12:1145–1151; 1996.
Matsuno, H.; Stassen, J. M.; Vermylen, J., et al. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 90:2203–2206; 1994.
Nakai, A.; Hirayama, C.; Ohtsuka, K., et al. Novel ATP-binding heat-inducible protein of Mr=37 000 that is sensitive to transformation in BALB/3T3 cells. J. Cell. Physiol. 143:577–589; 1990.
Oates, A. J.; Barraclough, R.; Rudland, P. S. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13:97–104; 1996.
Ou, X.; Ramos, K. S. Modulation of aortic protein phosphorylation by benzo(a)pyrene: implications in PAH-induced atherogenesis. J. Biochem. Toxicol. 7:147–154; 1992.
Pironin, M.; Clement, G.; Benzakour, O., et al. Growth in serum-free medium of NIH3T3 cells transformed by the EJ-Ha-ras oncogene: evidence for multiple autocrine growth factors.
Sadhu, D. N.; Lundberg, M. S.; Burghardt, R. C., et al. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype. J. Cell. Physiol. 161:490–500; 1994.
Sadhu, D. N.; Merchant, M.; Safe, S. H., et al. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo(a)pyrene. Arch. Biochem. Biophys. 300:124–131; 1993.
Stacey, D. W.; Kung, H.-F. Transformation of NIH3T3 cells by microinjection of Ha-ras protein. Nature 310:508–511; 1984.
Su, Z. Z.; Austin, V. N.; Zimmer, S. G., et al. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 8:1211–1219; 1993.
Wolfman, A.; Macara, I. G. Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature 325:359–361; 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parrish, A.R., Weber, T.J. & Ramos, K.S. Osteopontin overexpression in vascular smooth muscle cells transfected with the c-Ha-ras EJ oncogene. In Vitro Cell.Dev.Biol.-Animal 33, 584–587 (1997). https://doi.org/10.1007/s11626-997-0103-5
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11626-997-0103-5